RE:RE:RE:RE:bad news, really bad newsPROtrading wrote: Are you a naive fool or are you paid to be a bull on this smoking garbage dumpster???
All the "wheeling and dealing" here is typical of a "questionable" company. Don't you think they have a solid track record here for the gutter???
Don't be surprised one bit the 4 drugs were take out of AMCo right before the sale to Concordia. That's the problem with private companies, you have no idea the shell games and repackaging but all indications is that AMCo is a repackaged, overpriced Amdipharm & Mercury with all the junk pawned off to Concordia bagholders (none of the Directors and insiders! All fooled investors!)
That BS "unspecified, specified third party" held ownership of the 4 drugs, arranged that very odd vague clause in the AMCo sale "Considerations" and used "specified third party without specifying it!
The invoked it early summer to make it look like there were some new drugs being purchased! They not only over-paid for these $21M for these less than spectacular things, if you add the $72M liabiluty from the November Amco-Concordia deal and the additional "earn-out" on these 4 drugs, you get highway robbery.
And you fool are there "No! There can't be highway robbery? It's too outrageous"!?? Are you new to the markets buddy? You sure sound like a novice that crooks love to take advantage of!
Stop speculating, get management to answer your questions in writing. Otherwise, CROOKS love your kind. Guys who can't read the writing on the wall and only want to see what they want to see.
Lumberfeverlong wrote: Assuming that the four drugs were actually purchased by Amco, this actually dispells the rumour that an additional $72M will be payable to Cinven since that finder's fee was due to if Concordia purchased specified drugs from a specified third party introduced by Cinven to Concordia. If Cinven owned those drugs, how can a finder's fee be payable for Cinven introducing Concordia to itself? Use your God given brains people. Not to mention that it is completely ridiculaous that a finder's fee would be almost three times the purchase price.A finder's fee is usually in the 1 to 2% range not 200 to 300% range.
Lemerson wrote: TSX2016 wrote: https://www.medicines.org.uk/emc/PIL.29265.latest.pdf
Trazodone is actually bought from focus pharma and their address is the same as the headquater of AMOc. Longs are fxxxed.....More fees to pay to Cinven.
ummm Amco bought focus pharma in 2014
Please stopping talking nonsense, 72mil is not related to the four generics. See below email The fee relates to products we looked at back in Q4 2015 and didn't pursue. As an aside, we'd have an obligation to continue to disclose the possibility of that payment. Pls see page s 9 in attached: In addition, pursuant to the AMCo Purchase Agreement, if the Corporation acquires certain specified pharmaceutical products from a specified third party introduced to the Corporation by certain of the Vendors within 12 months of the Acquisition Closing, the Corporation will pay to the Vendors an additional US$72 million. Adam Peeler VP, Investor Relations & Communications 277 Lakeshore Rd. E, Suite 302, Oakville, ON L6J 1H9 Tel : 9058425150 ext. 240 Fax : 905-842-5154 Email : adam.peeler@concordiarx.com Web : www.concordiarx.com NOTICE OF CONFIDENTIALITY This e-mail, including all materials contained in or attached to this e-mail, contains proprietary and confidential information solely for the internal use of the intended recipient. If you have received this email in error, please notify us immediately by return e-mail or otherwise and ensure that it is permanently deleted from your systems, and do not print, copy, distribute or read its contents.